Ligand Pharmaceuticals (LGND) P/E (2010 - 2026)
Ligand Pharmaceuticals (LGND) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Ligand Pharmaceuticals (LGND) P/E is 39.09. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Ligand Pharmaceuticals (LGND)
| Year | P/E | Change |
|---|---|---|
| 2026 | 39.09 | +29.80% |
| 2025 | 30.11 | -102.00% |
| 2024 | -1.51K | -4102.22% |
| 2023 | 37.67 | -381.70% |
| 2022 | -13.37 | -97.38% |
| 2021 | -511.02 | -3.87% |
| 2020 | -531.61 | -4356.00% |
| 2019 | 12.49 | -22.17% |
| 2018 | 16.05 | -91.08% |
| 2017 | 180.02 | -252.78% |
| 2016 | -117.83 | -1354.67% |
| 2015 | 9.39 | -89.37% |
| 2014 | 88.36 | -9.75% |
| 2013 | 97.91 | -219.45% |
| 2012 | -81.96 | +513.09% |
| 2011 | -13.37 | -3.70% |
| 2010 | -13.88 | N/A |
Comparison Ligand Pharmaceuticals (LGND) P/E with competitors
Ligand Pharmaceuticals (LGND) P/E is 39.09.